Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2010
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010US20100204197 Pyrrolopyrimidines
08/12/2010US20100204191 Function-Selective Vitamin D Receptor Agonist
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204170 Heterobifunctional pan-selectin inhibitors
08/12/2010US20100204156 Use of thymopentin as a therapeutic agent
08/12/2010US20100204152 Use of gluten exorphin c : as a therapeutic agent
08/12/2010US20100204143 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
08/12/2010US20100204124 Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
08/12/2010US20100204123 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
08/12/2010US20100204122 Treatment of osteoporosis in peri- and post- menopausal women with hepcidin
08/12/2010US20100204102 Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same
08/12/2010US20100204087 Tribonectins
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203155 Segmented delivery system
08/12/2010US20100203146 Intermittent dosing strategy for treating rheumatoid arthritis
08/12/2010US20100203101 Bio-membrane for tissue regeneration
08/12/2010US20100203053 Method and composition for treating immune complex associated disorders
08/12/2010US20100203038 Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual
08/12/2010US20100203037 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis
08/12/2010US20100203020 Methods of generating, repairing and/or maintaining connective tissue in vivo
08/12/2010US20100203016 Pregnancy hormone combination for treatment of autoimmune diseases
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient
08/11/2010EP2215119A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
08/11/2010EP2215089A1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
08/11/2010EP2215079A1 Inhibitors of c-fms kinase
08/11/2010EP2214697A2 Nell-1 compositions
08/11/2010EP2214659A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
08/11/2010EP1699766B1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
08/11/2010EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament
08/11/2010CN201542233U Multifunctional shape-protecting health care medical pillow for babies
08/11/2010CN1899564B External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
08/11/2010CN1840162B Compound total extract of compound cape jasmine, ginger and fermented soybean, its preparation and use
08/11/2010CN101802011A mdl-1 uses
08/11/2010CN101801967A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same
08/11/2010CN101801931A Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
08/11/2010CN101801379A CSF-1R inhibitors for treatment of cancer and bone diseases
08/11/2010CN101801376A Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
08/11/2010CN101798558A Ant and ginseng wine
08/11/2010CN101798347A Monoclonal antibody for resisting high mobility group protein B1
08/11/2010CN101798333A Tetraterpene compound and derivatives thereof for treating cancer, inflammation and central nervous system diseases
08/11/2010CN101798285A Sinomenine derivate, synthesis method and application thereof
08/11/2010CN101797385A Oral calcium pharmaceutical composition
08/11/2010CN101797360A Fingerprint detection method for analgesic plaster
08/11/2010CN101797349A Plaster for treating traumatic injury and preparation method thereof
08/11/2010CN101797342A Traditional Chinese medicine for treating rheumatoid and chronic infectious arthritis
08/11/2010CN101797327A Chinese medicinal preparation for treating pain caused by orthopedic diseases
08/11/2010CN101797320A Medicine composition for preventing hyperosteogeny and preparation process thereof
08/11/2010CN101797309A Traditional Chinese medicine for treating scleriasis and venereal disease
08/11/2010CN101797293A Chinese medicinal pillow core for treating cervical spondylosis and preparation method thereof
08/11/2010CN101797291A Traditional Chinese medicine for treating osteoproliferation
08/11/2010CN101797278A Tripterygium wilfordii Hook.f total terpenoid vesicles and preparation method thereof
08/11/2010CN101797239A Strychnos alkaloid vesicle and preparation method thereof
08/11/2010CN101185663B Method for obtaining the extraction from caper medicinal part and application of the extraction
08/11/2010CN101181568B Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache
08/11/2010CN101181535B Method for preparing vertebral column rehabilitation pill
08/11/2010CN101116683B Medicine for treating arthritis
08/11/2010CN101057868B Preparation method of traditional Chinese medicine preparation for treating osteoporosis diseases and detection method
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772236 Substituted pyrazoles
08/10/2010US7772232 Quinazolinyl compounds as inhibitors of potassium channel function
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772000 Method and apparatus for mechanical stimulation of tissue in vitro
08/10/2010US7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
08/10/2010US7771744 Bazedoxifene acetate formulations
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2462132C 1,2,4-triazole compounds
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2361617C Uses of thank, a tnf homologue that activates apoptosis
08/10/2010CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087521A1 Combined preparation for treating joint diseases
08/05/2010WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
08/05/2010WO2010087454A1 Quinoline derivative
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010086736A2 Novel use of the combination of resveratrol with cysteine and derivatives thereof
08/05/2010WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases
08/05/2010WO2010063470A3 Methods for preventing or reducing colon carcinogenesis
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197796 Use of milnacipran or salt, excludes administering phenylalanine, tyrosine, or tryptophan
08/05/2010US20100197785 Omega-3 fatty acid fortified composition
08/05/2010US20100197744 Organic Compounds
08/05/2010US20100197726 Inhibitor of the differentiation of t cells into th1 cells
08/05/2010US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS
08/05/2010US20100197711 Benzothiazole compounds
08/05/2010US20100197705 Quinazolinone Derivatives Useful as Vanilloid Antagonists
08/05/2010US20100197676 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197637 Method of Treatment Using Bisphosphonic Acid
08/05/2010US20100197636 Injectable calcium-phosphate cement releasing a bone resorption inhibitor
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 820